4.4 Review

CDC7 as a novel biomarker and druggable target in cancer

Journal

CLINICAL & TRANSLATIONAL ONCOLOGY
Volume 24, Issue 10, Pages 1856-1864

Publisher

SPRINGER INT PUBL AG
DOI: 10.1007/s12094-022-02853-4

Keywords

CDC7; Cell cycle; Replication stress; Prognosis; CDC7 inhibitors

Categories

Funding

  1. Scientific and Technological Innovation Major Base of Guangxi [2018-15-Z04]
  2. Guangxi Key Research and Development Project
  3. Guangxi science and technology bases and talent special project [AD17129062]

Ask authors/readers for more resources

This article discusses the important role of cell division cycle 7 kinase in tumor treatment and recent studies on its function in normal human tissues and tumor cells. The article highlights the importance of CDC7 inhibitors and provides references for further clinical practice research.
Due to the bottlenecks encountered in traditional treatment for tumor, more effective drug targets need to be developed. Cell division cycle 7 kinase plays an important role in DNA replication, DNA repair and recombination signaling pathways. In this review, we first describe recent studies on the role of CDC7 in DNA replication in normal human tissues, and then we integrate new evidence focusing on the important role of CDC7 in replication stress tolerance of tumor cells and its impact on the prognosis of clinical oncology patients. Finally, we comb through the CDC7 inhibitors identified in recent studies as a reference for further research in clinical practice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available